Geographic pattern of cancers related to tobacco and alcohol in Connecticut: Implications for cancer control

Cancer Detection and Prevention

Volumn 28, Issue 4, 2004, Pages 302-308

  Polednak, Anthony P ^a  

^a Connecticut Tumor Registry ^*  (United States)

Author keywords

Esophageal cancer; Lung cancer; Oral cancer; Pharyngeal cancer

Indexed keywords

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ARTICLE; CANCER CONTROL; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; ESOPHAGUS CANCER; FEMALE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INFANT; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NEWBORN; PHARYNX CANCER; POVERTY; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; SOCIOECONOMICS; STANDARDIZATION; STATISTICAL SIGNIFICANCE; TOBACCO; UNITED STATES;

ADOLESCENT; ADULT; AGED; ALCOHOL DRINKING; CHILD; CHILD, PRESCHOOL; CONNECTICUT; EPIDEMIOLOGIC STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GEOGRAPHY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PHARYNGEAL NEOPLASMS; POVERTY; PREVENTIVE MEDICINE; RISK FACTORS; SEER PROGRAM; SMOKING; SMOKING CESSATION;

EID: 12344323394     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2004.03.005     Document Type: Article

References (42)

1. Devesa SS, Grauman DG, Blot WJ, Pennello G, Hoover RN, Fraumeni JF Jr. Atlas of Cancer Mortality in the United States, Washington DC:US Govt Printing Off, NIH Publ. No. (NIH) 99-4564;1950-94.
2. Brownson RC, Remington PL, Davis JR (Eds.). Chronic Disease Epidemiology and Control. Second ed. Washington DC: American Public Health Assoc.;1998. pp. 335-73.
3. US Department of Health and Human Services (DHHS) Reducing the Health Consequences of Smoking; 25 Years of Progress, a Report of the Surgeon General. Rockville MD:US DHHS Publication No. (CDC) 89-8411;1989.
4. Adami HO, Hunter D, Trichopoulos D (Eds). Textbook of Cancer Epidemiology. New York:Oxford University Press;2002.
5. National Cancer Institute. SEER Cancer incidence public-use database, 1973-1999. November 2001 submission. Bethesda MD;April 2002.
6. Ries LAG, Eisner MP, Hankey BF, Miller BA, Clegg L, Edwards BK (Eds). SEER Cancer Statistics Review, 1973-1999. National Cancer Institute. NIH Publication No. 97-2789. Bethesda MD. http://seer.cancer.gov/csr/1973_1999/2002.
7. Selvin S., Merrill D.W., Erdmann C., White M., Ragland K. Breast cancer detection: maps of 2 San Francisco Bay area counties. Am. J. Public Health. 88:1998;1186-1192
8. Arday D.R., Tomar S.L., Nelson D.E., Merritt R.K., Schooley M.W., Mowery P. State smoking prevalence estimates: a comparison of the Behavioral Risk Factor Surveillance System and Current Population Surveys. Am. J. Public Health. 87:1997;1665-1669
9. Flint A.J., Novotny T.E. 1983-1993: the independent risk of being poor. Tob. Control. 6:1997;14-18
10. National Center for Health Statistics. Health, United States, 2000, with adolescent health chartbook. Hyattsville MD:National Center for Health Statistics;2000.
11. US Bureau of the Census. 1990 Census of Population, Social and Economic Characteristics, Connecticut. 1990 CP-2-8, US Dept. of Commerce, issued September 1993.
12. Norusis MJ. SPSS Advanced Statistics 6.1. Chicago Il:SPSS Inc.;1994.
13. Flannery J.T., Boice J.D., Devesa S.S., Kleinerman R.A., Curtiss R.E., Fraumeni J.F. Jr. Cancer registration in Connecticut and the study of multiple primary cancers. Natl. Cancer Inst. Mongr. 68:1985;13-24
14. Stellman SD, Resnicow K. Tobacco smoking, cancer and social class. In: Kogevinas M, Pearce N, Susser M, Bofetta P, (Eds.). Social Inequalities and Cancer. IARC Scientific Publications No. 138. IARC:Lyon;1997. pp. 229-50.
15. Singh G.K., Miller B.A., Hankey B.F. Changing area socioeconomic patterns in US cancer mortality, 1950-1998: Part II lung and colorectal cancers. J. Natl. Cancer Inst. 94:2002;916-925
16. Greenfield T.K., Midanik L.T., Rogers J.D. 1984-1995: is the period of declining drinking over? Am. J. Public Health. 90:2000;47-52
17. Naimi T.S., Brewer R.D., Mokdad A., Denny C., Serdula M.K., Marks J.S. Binge drinking among US adults. JAMA. 289:2003;70-75
18. Nygren O, Adami HO. Esophageal Cancer. In Adami HO, Hunter D, Trichopoulos D (Eds.). Textbook of Cancer Epidemiology. New York:Oxford University Press;2002. pp. 137-61.
19. Jemal A., Grauman D., Devesa S. Recent geographic patterns of lung cancer and mesothelioma mortality rates in 49 shipyard counties in the United States, 1970-94. Am. J. Ind. Med. 37:2000;512-521
20. Diez-Roux A.V., Nieto F.J., Caulfield L., Tyroler H.A., Watson R.L., Szklo M. Neighborhood differences in diet: the Atherosclerosis Risk in Communities (ARIC) Study. J. Epidemiol. Commun. Health. 53:1999;55-63
21. Morland K., Wing S., Diez Roux A. The contextual effect of the local food environment on residents' diets: the Atherosclerosis Risk in Communities study. Am. J. Public Health. 92:2002;1761-1768
22. Castellsague X., Munoz N., De Stafani E., Victora C.G., Quintana M.J., Castelletto R., et al. Smoking and drinking cessation and risk of esophageal cancer (Spain). Cancer Causes Control. 11:2000;813-818
23. Fleming M.F., Mundt M.P., French M.T., Manwell L.B., Stauffacher E.A., Barry K.L. Benefit-cost analysis of brief physician advice with problem drinkers in primary care setting. Med. Care. 38:2000;7-18
24. Cromwell J., Bartosch W.J., Fiore M.C., Hasselblad V., Baker T. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking-cessation. JAMA. 278:1997;1759-1766
25. Yarnall K.S., Pollak K.I., Ostbye T., Krause K.M., Michener L. Primary care: is there enough time for prevention? Am. J. Public Health. 93:2003;635-641
26. Orleans C.T., Kristeller J.L., Gritz E.R. Helping hospitalized smokers quit: new directions for treatment and research. J. Consult Clin. Psychol. 61:1993;778-789
27. Stevens V.J., Glasgow R.E., Hollis J.F., Mount K. Implementation and effectiveness of a brief smoking-cessation intervention for hospital patients. Med. Care. 38:2000;451-459
28. Polednak A.P. Hospital-based smoking-cessation programs: a statewide survey. Conn. Med. 64:2000;683-685
29. Colditz G.A., Samplin-Salgado M., Ryan C.T., Dart H., Fisher L., Tokuda A., et al. Harvard report on cancer prevention, volume 5, fulfilling the potential for cancer prevention: policy approaches. Cancer Causes Control. 13:2002;199-212
30. Stoddard A.M., LaMontagne A.D., Emmons K., Hunt M.K., Youngstrom R., McLellan D., et al. A comprehensive worksite cancer control prevention intervention: behavior change results from a randomized controlled trial (United States). Cancer Causes Control. 13:2002;493-502
31. Schauffler H.H., Barker D.C., Orleans C.T. Medicaid coverage for tobacco-dependence treatments. Health Aff. 20:2001;298-303
32. Griffin K.W., Botvin G., Nichols T.R., Doyle M.M. Effectiveness of a universal drug abuse prevention approach for youths at high risk for substance abuse initiation. Prev. Med. 36:2003;1-7
33. Mahadevia P.V., Fleisher L.A., Frick K.D., Eng J., Goodman S.N., Powe N.R. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. JAMA. 289:2003;313-322
34. Belinsky S.A., Palmisano W.A., Gilliland F.D., Crooks L.A., Divine K.K., Winters S.A., et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 62:2002;2370-2377
35. Hirsch F.R., Franklin W.A., Gazdar A.F., Bunn P.A. Jr. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin. Cancer Res. 7:2001;5-22
36. Kurie J.M., Lotan R., Lee J.J., Lee J.S., Morice R.C., Liu D.D., et al. Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-B expression in the bronchial epithelium: results from a randomized placebo-controlled trial. J. Natl. Cancer Inst. 95:2003;206-214
37. Mayne S.T., Cartmel B., Baum M., Shor-Posner G., Fallon B.G., Briskin K., et al. Randomized trial of supplemental B-carotene to presents second head and neck cancer. Cancer Res. 61:2001;1457-1463
38. Kawahara M., Ushijima S., Kamimori N. Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking-cessation. Br. J. Cancer. 78:1998;409-412
39. Ostroff J.S., Jacobsen P.B., Moadel A.B., Spiro R.H., Shah J.P., Strong E.W., et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 75:1995;569-576
40. Ostroff J., Garland J., Moadel A., Fleshner N., Hay J., Cramer L., et al. Cigarette smoking patterns in patients after treatment of bladder cancer. J. Cancer Educ. 15:2000;86-90
41. Khuri F.R., Kim E.S., Lee J., Winn R.J., Behner S.E., Lippman S.M., et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol. Biomark. Prev. 10:2001;823-829
42. Schnoll R.A., Zhang B., Monstserrat R., Krook J.E., Spears W.T., Engstrom P.F. Brief physician-initiated quit smoking strategies for oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group. J. Clin. Oncol. 21:2003;355-365